Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease
PHASE2CompletedINTERVENTIONAL
Enrollment
37
Participants
Timeline
Start Date
May 31, 2013
Primary Completion Date
August 31, 2013
Study Completion Date
September 30, 2013
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG
glycopyrronium bromide
glycopyrronium bromide suspension in HFA
Trial Locations (1)
M23 9QZ
Medicines Evaluation Unit, Manchester
All Listed Sponsors
lead
Prosonix Limited
INDUSTRY
NCT01703624 - Dose Ranging Study of Glycopyrronium Bromide in Patients With Moderate or Severe Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter